Japanís Fuji Dream Airlines (FDA) has signed a
firm order with Embraer for two E175 jets.
The order has a value
of US$97.2 million, based on 2019 list prices.
ďWe are extremely pleased to continuously grow
our fleet and our relationship with Embraer,Ē said Yohei Suzuki,
Chairman and CEO of Fuji Dream Airlines. ďFDA currently operates
14 aircraft - three E170s and eleven E175s. These new aircraft
will give us the ability to grow our capacity, allowing us to add
more routes and frequencies, while also offering our passengers
the best cabin in its category.Ē
FDAís new E175s will be configured in a
single-class layout with 84 seats, with deliveries starting this
year. Embraer delivered the first E-Jet, an E170, to Fuji Dream
Airlines in 2009.
ďAfter nearly 10 years of operations, Fuji Dream
Airlines has established itself as an exemplary model for
sustainable growth with the support of the E175ís unrivaled
attributes underpinning the success of their continued network
expansion with new point-to-point services,Ē said Cesar Pereira,
Asia Pacific Vice President, Embraer Commercial Aviation. ďAs a
testament to Embraerís merits, there will be a total of 48 E-Jets
flying in Japan by the end of 2019. Of which, FDA's all-Embraer
fleet of 14 aircraft represents the largest of its kind in Asia
and has a world leading 99.83% dispatch reliability - yet another
example of how Embraer's products and customer support have been
setting new standards in the industry.Ē
FDA and Embraer have also signed an extension of
the Pool Program to cover its fleet of E170s and E175s, including
these new orders. The program includes the advance exchange and
repair management for more than 300 essential line replacement
units of the aircraft.
Fuji Dream Airlines,